Oesophageal motility disorders.
Kashyap
A S
AS
Kashyap
Surekha
S
D006152:Cyclic GMP / Q000502:physiology; D004311:Double-Blind Method; D015154:Esophageal Motility Disorders / Q000188:drug therapy* / Q000201:enzymology / Q000503:physiopathology; D006801:Humans; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology; D009569:Nitric Oxide / Q000502:physiology; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use*; D011312:Pressure; D011687:Purines; D000068677:Sildenafil Citrate; D013450:Sulfones; D013997:Time Factors; D016896:Treatment Outcome
D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D009569:Nitric Oxide; D000068677:Sildenafil Citrate; D006152:Cyclic GMP